DuPont Nutrition & Biosciences, a business unit of DowDuPont Specialty Products Division, has agreed to enhance the current portfolio of CR Alliance products by adding the Aquacoat range of modified release products.
Since 2007, the Alliance has served the needs of the pharmaceutical industry, providing customised solutions, products and support services for pharmaceutical product development.
The addition of the Aquacoat products into the Alliance portfolio demonstrates the continued strong relationship between distributor, Colorcon, and DuPont. Enhances the range of solutions provided to meet industry needs.
The Aquacoat product line includes Aquacoat ECD for sustained release and Aquacoat CPD for enteric coating applications. These aqueous functional coatings are designed for use in both pharmaceutical and nutritional solid dose applications. They provide modified release drug profiles with the added benefit of global regulatory acceptance.
Jayesh Parmar, General Manager at Colorcon said: “The addition of these products further augments the Alliance’s ability to fulfil the needs of the pharmaceutical industry and provide unique solutions to deliver efficiency, cost savings, and dependable performance.”
Colorcon’s global reach and unmatched technical support enables the expansion of these coating technologies to a wider base of customers around the world.
Pauel Fokin, Global Commercial Director of Pharma Solutions at DuPont said: “This move provides a one-stop shop for their controlled release application needs and demonstrates our continued commitment to the Controlled Release Alliance with Colorcon.”
